Literature DB >> 30953200

Healthcare spending and utilization following antireflux surgery: examining costs and reasons for readmission.

Kyle L Kleppe1,2, Yiwei Xu1, Luke M Funk1,2,3, Xing Wang1, Jeff A Havlena1, Jake A Greenberg1,2, Anne O Lidor4,5.   

Abstract

BACKGROUND: While clinical outcomes have been reported for anti-reflux surgery (ARS), there are limited data on post-operative encounters, including readmission, and their associated costs. This study evaluates healthcare utilization during the 90-day post-operative period following ARS including fundoplication and/or paraesophageal hernia (PEH) repair.
METHODS: Data were analyzed from the Truven Health MarketScan® Databases. Patients older than 16 years with an ICD-9 procedure code or Common Procedural Terminology (CPT) code for ARS and a primary diagnosis of GERD during 2012-2014 were selected. Healthcare spending and utilization on emergency department (ED) visits, performance of outpatient endoscopy, and readmission were examined. Reasons for readmission were classified based on ICD-9 code.
RESULTS: A total of 40,853 patients were included in the cohort with a mean age of 49 years and females comprising 76.0%. Mean length of stay was 1.4 days, and 93.0% of patients underwent a laparoscopic approach. The mean cost of the index surgical admission was $24,034. Readmission occurred in 4.2% of patients, and of those, 26.3% required a surgical intervention. Patients requiring one or more related readmissions accrued additional costs of $29,513. Some of the most common reasons for readmission were related to nutritional, metabolic, and fluid and electrolyte disorders. Presentation to the ED occurred in 14.0% of patients, and outpatient upper endoscopy was required in 1.5% of patients, but with much lower associated costs as compared to readmission ($1175).
CONCLUSION: The majority of patients undergoing ARS do not require additional care within 90 days of surgery. Patients who are readmitted accrue costs that almost double the overall cost of care compared to the initial hospitalization. Measures to attenuate potentially preventable readmissions after ARS may reduce healthcare utilization in this patient population.

Entities:  

Keywords:  Anti-reflux surgery; Costs; Healthcare utilization; Hiatal hernia; Paraesophageal hernia; Readmission

Year:  2019        PMID: 30953200     DOI: 10.1007/s00464-019-06758-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Same day discharge for benign laparoscopic hiatal surgery: a feasibility analysis.

Authors:  Juan Carlos Molina; Ana María Misariu; Ioana Nicolau; Jonathan Spicer; David Mulder; Lorenzo E Ferri; Carmen L Mueller
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

2.  Outcome of day-case laparoscopic fundoplication for gastro-esophageal reflux disease.

Authors:  C Mariette; J Boutillier; N Arnaud; G Piessen; N Ruolt; J-P Triboulet
Journal:  J Visc Surg       Date:  2011-01-26       Impact factor: 2.043

3.  Perioperative risk of laparoscopic fundoplication: safer than previously reported-analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009.

Authors:  Stefan Niebisch; Fergal J Fleming; Kelly M Galey; Candice L Wilshire; Carolyn E Jones; Virginia R Litle; Thomas J Watson; Jeffrey H Peters
Journal:  J Am Coll Surg       Date:  2012-05-10       Impact factor: 6.113

4.  Same-day discharge in benign esophageal surgery: a prospective cohort study.

Authors:  A Desbeaux; C Gronnier; G Piessen; M Vanderbeken; N Ruolt; J-P Triboulet; C Mariette
Journal:  Dis Esophagus       Date:  2017-04-01       Impact factor: 3.429

Review 5.  Ambulatory laparoscopic fundoplication for gastroesophageal reflux disease: a systematic review.

Authors:  Christophe Mariette; Patrick Pessaux
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

6.  Preventing Returns to the Emergency Department FollowingBariatric Surgery.

Authors:  Jennwood Chen; Justin Mackenzie; Yan Zhai; James O'Loughlin; Rebecca Kholer; Ellen Morrow; Robert Glasgow; Eric Volckmann; Anna Ibele
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

7.  Comparative Analysis of Perioperative Outcomes and Costs Between Laparoscopic and Open Antireflux Surgery.

Authors:  Francisco Schlottmann; Paula D Strassle; Marco G Patti
Journal:  J Am Coll Surg       Date:  2017-01-26       Impact factor: 6.113

8.  Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial).

Authors:  A M Grant; C Boachie; S C Cotton; R Faria; L Bojke; D M Epstein; C R Ramsay; B Corbacho; M Sculpher; Z H Krukowski; R C Heading; M K Campbell
Journal:  Health Technol Assess       Date:  2013-06       Impact factor: 4.014

Review 9.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag; Stephen Sweet; Christopher C Winchester; John Dent
Journal:  Gut       Date:  2013-07-13       Impact factor: 23.059

10.  Cost-effectiveness of Enhanced Recovery Versus Conventional Perioperative Management for Colorectal Surgery.

Authors:  Lawrence Lee; Juan Mata; Gabriela A Ghitulescu; Marylise Boutros; Patrick Charlebois; Barry Stein; A Sender Liberman; Gerald M Fried; Nancy Morin; Franco Carli; Eric Latimer; Liane S Feldman
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

View more
  2 in total

1.  Same-Day Home Recovery for Benign Foregut Surgery.

Authors:  Swee H Teh; Samuel C Schecter; Edgar B Servais; Kingsway Liu; Jonathan Svahn; Lisa Yang; Monica Goodstein; Richard Parent; Edward Chau; Lynn Chang; Minhoa Zhou; Sharon Shiraga; Michelle Knox
Journal:  JAMA Surg       Date:  2022-09-14       Impact factor: 16.681

2.  Examining emergency department utilization in the post-foregut surgery patient.

Authors:  Derek D Berglund; Tara McGraw; Alexandra Falvo; Voranaddha Vacharathit; Mustapha Daouadi; David Parker; Anthony Petrick
Journal:  Surg Endosc       Date:  2020-08-17       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.